Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A gained 1.740% today.
Bio-Rad Labs Inc. A is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 347 € there is a positive potential of 28.85% for Bio-Rad Labs Inc. A compared to the current price of 269.3 €.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | 1.740% | -1.966% | -4.673% | -17.189% | -14.263% | -31.823% | -41.201% |
| Icu Medical Inc. | 0.000% | 3.306% | 1.626% | -20.886% | -14.966% | -14.966% | -22.360% |
| Neogen Corp. | -2.480% | 13.592% | 4.464% | -51.250% | -51.250% | - | - |
| Haemonetics Corp. | -1.330% | 0.000% | 13.386% | - | - | - | - |
Comments
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BIO provided by MarketBeat